Studio Kiko Raises Pre-Series A
Studio Kiko raises a pre-Series A round from Smilegate Investment, Korea Investment Accelerator, and Strong Ventures to scale its ambient AI scribe platform.
Studio Kiko Raises Pre-Series A
Studio Kiko, a South Korean startup specializing in clinical AI documentation, has secured a pre-Series A round of funding. The company, headquartered in Korea, is the developer of Neardoc, an ambient AI scribe service designed to automate medical record creation for healthcare providers.
Investors
This funding round was participated in by Smilegate Investment, Korea Investment Accelerator, and Strong Ventures.
Studio Kiko Use of Funds
The company plans to use the new capital to support hiring initiatives and accelerate product development. Future goals include evolving Neardoc into a comprehensive clinical decision support system and a Medical OS, along with expanding into non-English-speaking Asian markets by 2027.
About Studio Kiko
Studio Kiko is a clinical AI startup that aims to improve healthcare infrastructure through its proprietary AI engine, Xynar. The company is led by CEO Sehoon Kim, CTO Kyungmuk Ryu, and Chief Medical Officer Changmin Lee, focusing on solutions that allow physicians to focus on patient care rather than administrative paperwork.
Funding Details
Company Website: https://neardoc.ai/
Company: Studio Kiko
Round: Pre-Series A
Funding Date: July 6, 2026
Investor: Smilegate Investment, Korea Investment Accelerator, Strong Ventures
Software Category: Healthcare AI
Source: https://en.wowtale.net/2026/07/07/234404/